Ping An Healthcare and Technology Company Limited (HKG:1833)
7.81
-0.24 (-2.98%)
Jun 18, 2026, 4:08 PM HKT
HKG:1833 Stock Forecast
Stock Price Forecast
According to 14 analysts polled by S&P Global, HKG:1833 stock has a consensus rating of "Buy" and an average price target of $15.56. The average 1-year stock price forecast is 99.23% higher than the current stock price, while the lowest is $9.15 (+17.16%) and the highest is $24.39 (+212.29%).
Price Target: $15.56 (+99.23%)
Analyst Consensus: Buy
* Price targets were last updated on May 16, 2026.
Analyst Ratings
The average analyst rating for HKG:1833 stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 1 | 1 | 1 | 1 |
| Sell | 1 | 1 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 1 | 1 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Unknown Analyst CICC No rating | CICC | Buy Maintains $14.20 | Buy | Maintains | $14.20 | +81.82% | May 16, 2026 |
Unknown Analyst UOB Kay Hian No rating | UOB Kay Hian | Buy Maintains $17.50 → $14.50 | Buy | Maintains | $17.50 → $14.50 | +85.66% | Apr 25, 2026 |
Unknown Analyst Morgan Stanley No rating | Morgan Stanley | Hold Maintains $16.80 | Hold | Maintains | $16.80 | +115.11% | Apr 23, 2026 |
Unknown Analyst GF Securities No rating | GF Securities | Buy Maintains $19.65 → $16.46 | Buy | Maintains | $19.65 → $16.46 | +110.76% | Apr 8, 2026 |
Unknown Analyst China Renaissance No rating | China Renaissance | Buy Maintains $23.88 | Buy | Maintains | $23.88 | +205.76% | Apr 5, 2026 |
Financial Forecast
Revenue This Year
5.96B
from 5.47B
Increased by 9.04%
Revenue Next Year
6.79B
from 5.96B
Increased by 13.83%
EPS This Year
0.21
from 0.20
Increased by 5.70%
EPS Next Year
0.28
from 0.21
Increased by 31.00%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 6.4B | ||
| Avg | 6.0B | ||
| Low | 5.7B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 16.9% | ||
| Avg | 9.0% | ||
| Low | 4.3% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 0.30 | ||
| Avg | 0.21 | ||
| Low | 0.13 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 49.2% | ||
| Avg | 5.7% | ||
| Low | -35.4% |